Clinical Trials Browser

Phase 2 × Terminated × PEGPH20 × Clear all

NCT02487277 2020-01-02

PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma

Phase 2 Terminated

3 enrolled 8 charts

Adenocarcinoma

NCT02910882 2019-04-11

HALO-IST

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms